For a tracheoesophageal fistula, what are the indications for using through‑the‑scope clips versus helix‑tacking devices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Endoscopic Management of Tracheoesophageal Fistula: Clips vs Helix Tacking

For tracheoesophageal fistulas, through-the-scope clips (TTSCs) and endosuturing alone are usually not effective; therefore, placement of a fully covered stent providing a snug fit is the primary recommendation, with over-the-scope clips (OTSCs) reserved for adjunctive closure attempts. 1

Primary Treatment Algorithm

First-Line Approach: Fully Covered Stent

  • Stenting is the mainstay for tracheoesophageal fistulas because clips and suturing devices alone typically fail to achieve durable closure 1
  • The stent must provide a snug fit with diameter slightly wider than the natural esophageal diameter to seal the fistula without expanding the defect
  • Proximal stent fixation is mandatory using either endosuturing or a stent-fixing device, as there is no stricture to anchor the stent 1

Role of Clips in TEF Management

Over-the-Scope Clips (OTSCs):

  • Effective for defects 1-2 cm in size with 85.3% clinical success rate 1
  • Failure occurs with defects >2 cm or closure attempts >72 hours after perforation 1
  • Can be used as adjunctive therapy with stenting for complex fistulas 2
  • Requires endoscope withdrawal and reinsertion with device mounted (tip diameter increases to 16.5-21 mm) 1

Through-the-Scope Clips (TTSCs):

  • Not recommended as monotherapy for established TEF 1
  • May be used for small mucosal perforations during procedures (e.g., POEM) but inadequate for true fistulas 1

Helix Tacking System (X-Tack)

Indications for helix tacking:

  • Large or irregular-shaped defects that cannot be closed with standard clips 1
  • Situations where endoscope withdrawal is problematic (e.g., right colon, tortuous anatomy) 1
  • Adjunctive closure with other devices for complex fistulas 3
  • Achieves 77.2% complete closure alone, 95.2% with adjunctive clips 4

Advantages over traditional clips:

  • Deployed through standard gastroscopes/colonoscopes without endoscope withdrawal 1
  • Allows closure of defects averaging 34.3 mm 4
  • Can be deployed in Z-shape pattern to approximate fibrotic edges 3

Clinical Decision Framework

For Fresh Post-Operative TEF (Within Days):

  1. Attempt primary closure with TTSCs, OTSCs, or endosuturing
  2. Always add fully covered stent regardless of clip placement success 1

For Established TEF:

  1. Primary: Fully covered stent with proximal fixation 1
  2. Consider OTSC if defect <2 cm and <72 hours old 1
  3. Consider helix tacking for irregular defects or when endoscope withdrawal is problematic 1, 4, 3

For Complex/Large TEF:

  1. Bridging tracheal stent placement to cover fistula 2
  2. Definitive closure with OTSC after stabilization 2
  3. Helix tacking with anchor-pronged clips for enhanced tissue grasping 3

Critical Pitfalls to Avoid

  • Never rely on TTSCs or endosuturing alone for established TEF—failure is expected 1
  • Do not place esophageal stents without proximal fixation—high migration rates without stricture to anchor 1
  • Avoid OTSC attempts if defect >2 cm or >72 hours old—success rates plummet 1
  • Do not use oversized stents—this expands rather than seals the defect 1
  • For cervical esophagus with prior surgery/radiation, use caution with OTSC due to non-smooth cap edges 1

Alternative/Adjunctive Therapies

Endoscopic vacuum therapy:

  • 90% healing rate for anastomotic leaks, 96% for perforations 1
  • Consider for large or persistent fistulas not amenable to clips or stents
  • Median therapy duration 17 days 1

Adverse event rate for helix tacking system: 5.4% 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.